Alessia Argentieri
Follow Alessia Argentieri
Articles by Alessia Argentieri
OpenGate heads for third fund launch targeting up to $700m
GP is currently investing its second fund, which held a final close on $585m in November 2019
IGI buys OME Group
GP invests in the company via IGI Investimenti Sei, which held a €170m final close in July 2020
Neuberger Berman launches ELTIF
Fund focuses on buyout opportunities blended with some growth and structured equity
Astorg, Bridgepoint buy Fenergo from Insight Partners
Media report values the business at $1.16bn, with the two GPs buying their stake for $600m
General Atlantic leads €276m round for €2.6bn-valued Back Market
Round sees participation from Generation Investment Management, Aglaé, Eurazeo, Goldman Sachs and Daphni
Appian Capital appoints Pinto as chief financial officer
Pinto will lead the investment strategy of Appian, which specialises in assets across the mining sector
Top Tier Capital closes European fund on €260m
Fund makes primary and secondary investments in venture capital funds and co-investments in select portfolio companies
Wise Equity invests in Selle Royal
GP backs the company via its fund Wisequity V, which closed on its €260m hard-cap in July 2019
Oxy Capital backs GPack
Deal includes the restructuring of around €60m in debt and the injection of fresh funds, as well as managerial support
Alpha appoints Zanotelli as director in Italy
In his new role, Livio Zanotelli will focus on identifying new investment opportunities across Italy
Neuberger exits Service Med to MedicAir
GP sells its 75% stake in the medical company, controlled via Atlante Private Equity Fund
Sanne rejects Cinven's £1.3bn offer
Cinven's proposal amounts to 830 pence per share, representing a 37.6% premium to Sanne's shares price of 603 pence
Eurazeo launches PME IV Fund
Eurazeo's PME arm deploys equity tickets of €20-100m, focusing on French mid-market businesses with EV of €50-200m
Abénex backs medical imaging software provider EDL
GP plans to support the company in boosting its organic growth and accelerating its expansion through targeted add-ons
Eurazeo sells 49% stake in Trader Interactive in $1.6bn deal
With this sale, Eurazeo reaps a 1.5x return on its initial investment, made in 2017 alongside Goldman Sachs
Eurazeo invests in I-Tracing in €165m deal, Keensight exits
Following the deal, Sagard NewGen invests as a minority shareholder in a holding company controlled by Eurazeo
Keensight sells LinkByNet to Accenture
Deal ends a five-year holding period for Keensight, which invested €50m in LinkByNet in exchange for a minority stake
UI Investissement, Geneo back clinic operator GBNA
UI and Geneo invest in the company via a capital increase, partnering with the Guichard family
Neo Investment exits restaurant chain Obicà
Sale ends a nine-year holding period for Neo Investments, which acquired a 52% stake in Obicà from the company's founders
Abingworth Clinical Co-Development Fund 2 closes on $582m
ACCD 2 finances the development of late-stage clinical programmes of pharmaceutical and biotechnology companies
Bain Capital buys Valeo from CapVest
Bain intends to further boost the company's growth both organically and through acquisitions
Capza 5 Flex Equity Fund closes on €700m
Fund offers flexible financing that combines majority and minority equity, convertible bonds and mezzanine
Advent leads $220m series-D for Shift at $1bn valuation
Avenir, Accel, Bessemer Venture Partners, General Catalyst and Iris Capital also take part in the round
Azimut buys 30% stake in VC house P101
With this partnership, Azimut and P101 intend to develop a European platform to fuel the growth of innovative companies